
|Articles|May 10, 2004
Investigational bulking agent for SUI provides durable efficacy at1 year
After 1 year of follow-up, women with stress urinary incontinence treatedwith an investigational bulking agent containing ethylene vinyl alcoholdissolved in a dimethyl sulfoxide carrier (EVOH/DMSO, Uryx) are demonstratingdry and improved outcomes more often than controls receiving injectablecollagen (Contigen), investigators from a multicenter study reported yesterday.
Advertisement
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves lutetium Lu 177 vipivotide tetraxetan for PSMA-positive mHSPC
2
Laura Bukavina, MD, and Gabriela Díaz, MD, on the rise of young-onset bladder cancer
3
Individualizing androgen pathway therapy in mCSPC
4
BOND-003 Cohort C: Efficacy Results
5







